Antios Therapeutics Raises $75 Million in a Series B-1 Funding to Advance Clinical Programs for HBV November 3, 2021 Read More ›
Neuros Medical Announces Completion of Enrollment in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain September 15, 2021 Read More ›
4D Molecular Therapeutics Reports Financial Results for the Second Quarter of 2021 and Provides Operational Highlights August 12, 2021 Read More ›
Monte Rosa Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress August 12, 2021 Read More ›
Arbutus Biopharma and Antios Therapeutics Announce Clinical Collaboration Agreement to Evaluate AB-729 in Combination with ATI-2173 in Subjects with Chronic Hepatitis B Virus Infection June 29, 2021 Read More ›
